
Biosimulation in Drug Development
Kurzinformation



inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
This first comprehensive survey to cover all pharmaceutically relevant topics provides a comprehensive introduction to this novel and revolutionary tool, presenting both concepts and application examples of biosimulated cells, organs and organisms. Following an introduction to the role of biosimulation in drug development, the authors go on to discuss the simulation of cells and tissues, as well as simulating drug action and effect. A further section is devoted to simulating networks and populations, and the whole is rounded off by a look at the potential for biosimulation in industrial drug development and for regulatory decisions. Part of the authors are members of the BioSim Network of Excellence that encompasses more than 40 academic institutions, pharmaceutical companies and regulatory authorities dealing with drug development; other contributors come from industry, resulting in a cross-disciplinary expert reference.
Produktdetails

So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
Martin Bertau is Professor of Technical Chemistry at Freiberg University of Mining and Technology. He received his PhD in organic chemistry from Freiburg University, Germany, in 1997. He then ran the biotechnology division of Rohner Ltd. in Basle, Switzer
- hardcover
- 464 Seiten
- Erschienen 2022
- Wiley
- hardcover
- 606 Seiten
- Erschienen 2006
- Wiley-VCH
- Gebunden
- 386 Seiten
- Erschienen 2012
- Wiley-VCH
- hardcover
- 259 Seiten
- Erschienen 1999
- Springer
- Gebunden
- 370 Seiten
- Erschienen 2011
- Wiley-VCH
- Hardcover
- 316 Seiten
- Erschienen 2013
- Springer
- Hardcover
- 288 Seiten
- Erschienen 2024
- ISTE LTD
- Hardcover
- 480 Seiten
- Erschienen 1980
- Wiley-Interscience